Raviskeemid

Raviskeemid is the Estonian term for treatment regimens, referring to standardized plans that specify the medicines, dosages, routes, timing, and duration used to manage a health condition. They are designed to translate clinical guidelines into concrete steps for care and are applied in hospitals, clinics, and community health settings. A raviskeem typically lists the active substances, dose and schedule, route of administration, treatment duration, monitoring requirements, and criteria for modification or discontinuation.

Development and governance involve clinical guidelines committees, national formularies, and regulatory authorities that review evidence from clinical trials and real-world data. Raviskeemid may be updated as new evidence becomes available or as resistance patterns, safety data, or drug availability change. Implementation aims to improve treatment efficacy, safety, and patient adherence, while reducing variation in care. It also supports pharmacovigilance by providing standardized means to record outcomes and adverse effects.

Common domains include infectious diseases (antibiotic and antiviral regimens), oncology (chemotherapy protocols), and chronic diseases (antihypertensive, antidiabetic, or lipid-lowering regimens). In antibiotic stewardship, raviskeemid help ensure appropriate selection and duration to minimize resistance. The approach increasingly incorporates patient-specific factors and, where available, pharmacogenetic information to personalize regimens, aligning with precision medicine.

The term is used mainly within Estonian-speaking medical contexts and appears in national guidelines, medical software, and institutional policies.